Updated Recommendations for the Use of Varicella and MMR Vaccines In HIV-Infected Individuals: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) †
Tan, B.; Ismail, S.
Canada Communicable Disease Report 36(Acs-7): 1-19
2010
ISSN/ISBN: 1188-4169 PMID: 31682653 Accession: 069479137
PDF emailed within 1 workday: $29.90
Related References
Tan, B.; Ismail, S. 2010: Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-8): 1-26Desai, S.; McGeer, A.; Quach-Thanh, C.; Elliott, D. 2010: Update on the Use of Conjugate Pneumococcal Vaccines in Childhood: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-12): 1-21
Dawar, D.M.; Harris, M.T.; McNeil, D.S. 2012: Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 38(Acs-1): 1-62
Campbell, A.; Ismail, S.; Tan, B. 2010: Literature Review on One-Dose and Two-Dose Varicella Vaccination: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-10): 1-24
De Serres, G. 2000: An Advisory Committee Statement (ASC). National Advisory Committee on Immunization (NACI). Statement on adult/adolescent formulation of combined acellular pertussis, tetanus, and diphtheria vaccine Canada Communicable Disease Report 26: 1-8
2003: An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2003-2004 season Canada Communicable Disease Report 29: 1-20
2000: Statement on alternate adolescent schedule for hepatitis B vaccine (ACS-5). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI) Canada Communicable Disease Report 26: 19-20
1998: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1998-1999 season Canada Communicable Disease Report 24: 1-12
Tam, T.; Langley, J. 2004: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: statement on influenza vaccination for the 2003-04 season Canada Communicable Disease Report 30: 1-5
Orr, P. 2004: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2004-2005 season Canada Communicable Disease Report 30: 1-32
Ford-Jones, E.L.; Calvin, S. 2010: Literature Review on Rotavirus: Disease and Vaccine Characteristics: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-14): 1-31
1997: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on hepatitis prevention Canada Communicable Disease Report 23: 1-6
2000: Supplementary statement on hepatitis A vaccine (ACS-4). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI) Canada Communicable Disease Report 26: 12-18
2002: An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). Statement on smallpox vaccination Canada Communicable Disease Report 28(Acs-1): 1-12
2001: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on influenza vaccination: continued use of Fluviral influenza vaccine in the 2000-2001 season Canada Communicable Disease Report 27: 1-3
Langley, J.; Warshawsky, B.; Virani, S.; Hanrahan, A.; Laupland, K.; McGeer, A.; McNeil, S.; Seifert, D.; Sicard, N.; Senikas, V. 2009: Evidence-based recommendations for immunization--methods of the National Advisory Committee on Immunization. An Advisory Committee Statement (ACS) Canada Communicable Disease Report 35(Acs-1): 1-10
1992: National Advisory Committee on Immunization (NACI). Statement on Haemophilus influenzae type B conjugate vaccines for use in infants and children Canada Communicable Disease Report 18(23): 169-176
Gemmill, I. 2003: National Advisory Committee on Immunization (NACI). Statement on thimerosal Canada Communicable Disease Report 29: 1-10
1994: National Advisory Committee on Immunization (NACI). Statement on the prevention of hepatitis A infections Canada Communicable Disease Report 20(16): 133-143
Carter, A.O.; Walsh, P. 1991: National Advisory Committee on Immunization (NACI) statement on universal immunization against hepatitis B Canada Diseases Weekly Report 17(31): 165-171